Improved quantification of HIV-1-infected CD4+ T cells using an optimised method of intracellular HIV-1 gag p24 antigen detection

Improved quantification of HIV-1-infected CD4+ T cells using an optimised method of intracellular HIV-1 gag p24 antigen detection

Show other versions (1)

The capacity of CD8+ T cells to inhibit HIV-1 replication in vitro strongly correlates with virus control in vivo. Post-hoc evaluations of HIV-1 vaccine candidates suggest that this immunological parameter is a promising benchmark of vaccine efficacy. Large-scale analysis of CD8+ T cell antiviral ac...

Full description

Bibliographic Details
Main Authors:	Yang, H, Yorke, E, Hancock, G, Clutton, G, Sande, N, Angus, B, Smyth, R, Mak, J, Dorrell, L
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Improved quantification of HIV-1-infected CD4+ T cells using an optimised method of intracellular HIV-1 gag p24 antigen detection.
by: Yang, H, et al.
Published: (2013)

Flow-Cytometry Intracellular Detection and Quantification of HIV1 p24 Antigen and Immunocheckpoint Molecules in T Cells among HIV/AIDS Patients
by: Tessema B, et al.
Published: (2022-08-01)

Lymphoproliferative responses to HIV-1 Gag p24 antigen and mitogens in HIV-1 subtype CRF01_AE infected Thai patients and HIV-1 seronegative donors
by: Kim Silvia R, et al.
Published: (2006-12-01)

Evaluation of circulating gut-homing T cells as a marker of HIV-1 progression and immune reconstitution
by: Dorrell, L, et al.
Published: (2014)

The Life-Cycle of the HIV-1 Gag–RNA Complex
by: Elodie Mailler, et al.
Published: (2016-09-01)

MAL Inhibits the Production of HIV-1 Particles by Sequestering Gag to Intracellular Endosomal Compartments
by: Kei Miyakawa, et al.
Published: (2022-03-01)

T cell responses to peptides covering the gag p24 region of HIV-1 occur in HIV-1 seronegative individuals.
by: Vyakarnam, A, et al.
Published: (1991)

Emergence of a distinct HIV-specific IL-10-producing CD8+ T-cell subset with immunomodulatory functions during chronic HIV-1 infection.
by: Clutton, G, et al.
Published: (2013)

Mosaic HIV-1 Gag antigens can be processed and presented to human HIV-specific CD8+ T cells.
by: Ndhlovu, Z, et al.
Published: (2011)

Role of the HIV-1 Matrix Protein in Gag Intracellular Trafficking and Targeting to the Plasma Membrane for Virus Assembly
by: Ruba H Ghanam, et al.
Published: (2012-02-01)

Detection of broad functional gag-specific CD4+T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
by: Ondondo, B, et al.
Published: (2006)

Effects of reduced gag cleavage efficiency on HIV-1 Gag-Pol package
by: Yi-Ru Lin, et al.
Published: (2022-04-01)

Detection of broad functional gag-specific CD4+ T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
by: Rowland-Jones Sarah L, et al.
Published: (2006-12-01)

P17-14. Fitness-informed HIV-1 Gag-p24 vaccine design
by: Nickle DC, et al.
Published: (2009-10-01)

Comprehensive analysis of HIV Gag-specific IFN-gamma response in HIV-1- and HIV-2-infected asymptomatic patients from a clinical cohort in The Gambia.
by: Ondondo, B, et al.
Published: (2008)

Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol.
by: Anna Figueiredo, et al.
Published: (2006-11-01)

Abrogation of contaminating RNA activity in HIV-1 Gag VLPs
by: Shephard Enid G, et al.
Published: (2011-10-01)

Gag and protease co-evolution modeling for HIV-1
by: Wang, Junjie
Published: (2014)

Recombinant DNA/MVA/ChAdV-63-elicited T cells specific for conserved regions of the HIV-1 proteome recognize HIV-1 infected cells and suppress HIV-1
by: Ahmed, T, et al.
Published: (2012)

Recombinant DNA/MVA/ChAdV-63-elicited T cells specific for conserved regions of the HIV-1 proteome recognize HIV-1 infected cells and suppress HIV-1
by: Ahmed T, et al.
Published: (2012-09-01)

An ultrasensitive planar array p24 Gag ELISA to detect HIV-1 in diverse biological matrixes
by: Callie Levinger, et al.
Published: (2021-12-01)

Antiviral Inhibitory Capacity of CD8+ T cells Predicts the Rate of CD4+ T-Cell Decline in HIV-1 Infection
by: Yang, H, et al.
Published: (2012)

Antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ T-cell decline in HIV-1 infection.
by: Yang, H, et al.
Published: (2012)

pTHr.HIVA and MVA.HIVA vaccines (gag p24/p17) augment CD4+T cell responses in chronically infected HIV-1 patients on HAART
by: Ondondo, B, et al.
Published: (2005)

HIV-1 subtype A gag variability and epitope evolution
by: Abidi, S, et al.
Published: (2014)

Relationship between HIV-1 Gag Multimerization and Membrane Binding
by: Christopher Sumner, et al.
Published: (2022-03-01)

Recent Advances in HIV-1 Gag Inhibitor Design and Development
by: Alexej Dick, et al.
Published: (2020-04-01)

3D structural modeling of HIV-1 GAG protein
by: Xu, Xiao Yan.
Published: (2011)

HIV-1 subtype A gag variability and epitope evolution.
by: Syed Hani Abidi, et al.
Published: (2014-01-01)

Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine.
by: Dorrell, L, et al.
Published: (2005)

Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests.
by: Beatrice N Vetter, et al.
Published: (2014-01-01)

Gag-Gag Interactions Are Insufficient to Fully Stabilize and Order the Immature HIV Gag Lattice
by: Ipsita Saha, et al.
Published: (2021-09-01)

Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity
by: Kazuaki Monde, et al.
Published: (2017-04-01)

IL-10 Receptor Blockade Enhances CD4 and CD8 T Cell Responses to a Simian Adenovirus-Vectored HIV-1 Vaccine, ChAdV63.HIVconsv
by: Clutton, G, et al.
Published: (2013)

HIV-1 Subtype C gag-specific T-cell responses in relation to human leukocyte antigens in a diverse population of HIV-infected Ethiopians.
by: Tsegaye, A, et al.
Published: (2007)

CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype
by: Gillespie, G, et al.
Published: (2005)

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.
by: Fitzgerald, J, et al.
Published: (2003)

CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
by: Gillespie, G, et al.
Published: (2005)

Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses.
by: Ondondo, B, et al.
Published: (2006)

IQGAP1 Negatively Regulates HIV-1 Gag Trafficking and Virion Production
by: Yosef Sabo, et al.
Published: (2020-03-01)